ORTEXORTEX News
Tracking COP? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CO
ConfluenceCOP

COP Earnings Eve: Put Buyers Double Down, Cost to Borrow Spikes 79%

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 4 Nov 2026, 12:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ConocoPhillips reports Q3 results tomorrow, November 5, and the positioning data has shifted again. The put/call ratio reached 0.8159 on Monday, 2.06 standard deviations above its 20-day mean of 0.754. Cost to borrow jumped 79% over the past week to 0.52%. Both moves extend the defensive tilt that has built since late October, but neither points to a structurally constrained borrow market.

Why this matters

The stock shed 2.4% over the past week, outperforming the median decline of 4.7% across its closest peers. Despite that relative resilience, options traders have continued to add downside protection. The PCR of 0.8159 is not at its 52-week extreme (the high is 0.9967), but its two-standard-deviation-plus reading heading into a known binary event is the notable fact. Three datasets are now moving in the same direction the day before the print: options skew, short interest, and borrowing cost.

Converging Signals

The PCR has risen from around 0.71 at the start of October to 0.8159 now. That is a steady grind higher, not a single session spike, which makes the current reading harder to dismiss as noise.

Short interest sits at 1.48% of the free float as of November 3. That is low in absolute terms. But it has climbed roughly 16% over the past month from a base of around 1.27%. The pace matters more than the level here.

Cost to borrow at 0.52% is not expensive for a large-cap name, and borrow availability remains effectively unlimited. There is no structural squeeze risk. The 79% weekly rise in cost to borrow likely reflects incremental demand from investors establishing short-dated hedges rather than any tightening in underlying supply.

Context: Analysts and Price

The analyst consensus sits above the current price. Morgan Stanley (Overweight, $159), Susquehanna (Positive, $175), and Jefferies (Buy, $174) all raised targets in October. Piper Sandler assumed coverage on October 27 with a Neutral rating and a $157 target. The mean price target is $151.56, with COP trading at $144.40.

The stock is up roughly 14% over the past month. That run, against a backdrop of mixed energy sector performance, is part of what the options market appears to be insuring against. The bear case is straightforward: a stock up 14% in a month heading into earnings has limited margin for disappointment. Prior Q3 prints moved COP about 2.2% on the day and 8.2% over the following five days.

Wikipedia page views registered a z-score of 3.0 against their own 90-day average as of October 28, indicating elevated retail attention relative to recent norms.

What to Watch

The November 5 print is the near-term checkpoint. Watch whether the PCR retreats sharply after results, which would suggest the hedges were event-driven and are being unwound, or whether the ratio stays elevated, which would suggest the defensive positioning reflects a view that extends beyond a single quarter's numbers.


  • COP price (Nov 3 close): $144.40, down 2.4% over one week
  • Put/call ratio: 0.8159, z-score of 2.06 vs 20-day mean
  • SI % of free float: 1.48%, up roughly 16% over one month
  • Cost to borrow: 0.52%, up 79% over one week
  • Borrow availability: abundant, no structural constraint
  • Earnings: November 5, pre-market
  • Consensus mean price target: $151.56

Stocks in this article

See the live data behind this article on ORTEX.

Open COP on ORTEX →

How this article was generated

Generated
4 Nov 2026, 12:09
Data as of
4 Nov 2026, 12:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.